nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

09.11.2016 | Rhinology

Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study

verfasst von: V. Gudziol, M. Michel, C. Sonnefeld, D. Koschel, T. Hummel

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Oral aspirin challenge (OAC) reveals aspirin-exacerbated respiratory disease (AERD) in approximately 50% of unselected patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). Smell loss is one factor that predicts the outcome of OAC. The present study aims to unveil differences in olfactory function between patients with CRSwNP with and without AERD by means of a validated reliable test for odor threshold, discrimination and identification. Additionally, Beck Depression Inventory (BDI) and Sinonasal Outcome Test 22 (SNOT 22) were applied. 31 patients were tested before and 7 months after OAC and aspirin desensitization in case of diagnosed AERD. AERD was diagnosed in 16 and excluded in 15 patients. Patients with AERD demonstrated significantly more olfactory loss, but no difference in BDI or SNOT 22 at baseline. Olfaction of the groups equalized at follow-up. Sinonasal complaints decreased significantly in patients with AERD, but not in the group without AERD. Olfactory loss is a valuable marker for AERD, but due to the variance of olfactory test results prediction of AERD by exclusively any of the applied olfactory tests appears unreliable.

Childs MA, Breau RH, Umbreit EC, Lohse CM, Cheville JC, Thompson RH, Blute ML, Leibovich BC (2011) Metachronous renal tumours after surgical management of oncocytoma. BJU Int 108(6):816–819. doi:10.1111/j.1464-410X.2010.09946.x PubMed

Blomqvist EH, Lundblad L, Anggard A, Haraldsson PO, Stjarne P (2001) A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allerg Clin Immunol 107(2):224–228CrossRef

Umbreit C, Virchow JC, Thorn C, Hormann K, Klimek L, Pfaar O (2010) Aspirin-Intolerance-Syndrome: a common and interdisciplinary disease. Internist (Berl) 51(9):1196–1198. doi:10.1007/s00108-010-2661-y CrossRef

Widal MF, Abramin P, Lermoyez J (1922) Anaphylaxie et idiosyncrasie. Presse Med 30:189

Lee RU, Stevenson DD (2011) Aspirin-exacerbated respiratory disease: evaluation and management. Allerg Asthma Immunol Res 3(1):3–10. doi:10.4168/aair.2011.3.1.3 CrossRef

Stevenson DD, Pleskow WW, Simon RA, Mathison DA, Lumry WR, Schatz M, Zeiger RS (1984) Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. J Allerg Clin Immunol 73(4):500–507. doi:10.1016/0091-6749(84)90361-0 CrossRef

Berges-Gimeno MP, Simon RA, Stevenson DD (2003) Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allerg Clin Immunol 111(1):180–186CrossRef

Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P, Kaulbach H, Rozniecki J, Kaliner MA (1993) Nasal secretions in response to acetylsalicylic acid. J Allerg Clin Immunol 91(2):580–598CrossRef

Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA (1996) Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allerg Clin Immunol 98:751–758CrossRef

10.

Sweet JM, Stevenson DD, Simon RA, Mathison DA (1990) Long-term effects of aspirin desensitization–treatment for aspirin-sensitive rhinosinusitis-asthma. J Allerg Clin Immunol 85(1 Pt 1):59–65CrossRef

11.

Dursun AB, Woessner KA, Simon RA, Karasoy D, Stevenson DD (2008) Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allerg Asthma Immunol 100(5):420–425. doi:10.1016/S1081-1206(10)60465-6 CrossRef

12.

Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, Keck T (2008) Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 63(9):1228–1234CrossRefPubMed

13.

Gudziol V, Buschhuter D, Abolmaali N, Gerber J, Rombaux P, Hummel T (2009) Increasing olfactory bulb volume due to treatment of chronic rhinosinusitis-a longitudinal study. Brain 132(Pt 11):3096–3101CrossRefPubMed

14.

Fruth K, Pogorzelski B, Schmidtmann I, Springer J, Fennan N, Fraessdorf N, Boessert A, Schaefer D, Gosepath J, Mann WJ (2013) Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy 68(5):659–665. doi:10.1111/all.12131 CrossRefPubMed

15.

Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 34(5):447–454. doi:10.1111/j.1749-4486.2009.01995.x CrossRefPubMed

16.

Katotomichelakis M, Simopoulos E, Tzikos A, Balatsouras D, Tripsianis G, Danielides G, Xenitidis K, Livaditis M, Danielides V (2014) Demographic correlates of anxiety and depression symptoms in chronic sinonasal diseases. Int J Psychiatry Med 48(2):83–94. doi:10.2190/PM.48.2.a CrossRefPubMed

17.

Scogin F, Beutler L, Corbishley A, Hamblin D (1988) Reliability and validity of the short form Beck Depression Inventory with older adults. J Clin Psychol 44(6):853–857CrossRefPubMed

18.

Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) “Sniffin’ sticks”: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22(1):39–52CrossRefPubMed

19.

Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243CrossRefPubMed

20.

Ehrenstein WH, Ehrenstein A (1999) Psychophysical methods. In: Windhorst U, Johansson H (eds) Modern techniques in neuroscience research. Springer, Berlin, pp 1211–1241CrossRef

21.

Hummel T, Knecht M, Kobal G (1996) Peripherally obtained electrophysiological responses to olfactory stimulation in man: electro-olfactograms exhibit a smaller degree of desensitization compared with subjective intensity estimates. Brain Res 717(1–2):160–164CrossRefPubMed

22.

Köster EP, de Wijk RA (1991) Olfactory adaptation. In: Laing DG, Doty RL, Breipohl W (eds) The human sense of smell. Springer, Berlin, pp 199–215CrossRef

23.

Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wohrl S, Dahlen B, Szczeklik A (2007) EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62(10):1111–1118CrossRefPubMed

24.

Fountain CR, Mudd PA, Ramakrishnan VR, Sillau SH, Kingdom TT, Katial RK (2013) Characterization and treatment of patients with chronic rhinosinusitis and nasal polyps. Ann Allerg Asthma Immunol 111(5):337–341. doi:10.1016/j.anai.2013.07.017 CrossRef

25.

Landis BN, Hummel T, Hugentobler M, Giger R, Lacroix JS (2003) Ratings of overall olfactory function. Chem Senses 28(8):691–694CrossRefPubMed

26.

Hornung DE, Kurtz DB, Bradshaw CB, Seipel DM, Kent PF, Blair DC, Emko P (1998) The olfactory loss that accompanies an HIV infection. Physiol Behav 15:549–556CrossRef

27.

Jones-Gotman M, Zatorre RJ (1988) Olfactory identification deficits in patients with focal cerebral excision. Neuropsychologia 26:387–400CrossRefPubMed

28.

Jones-Gotman M, Zatorre RJ (1988) Contribution of the right temporal lobe to odor memory. Epilepsia 29:661

29.

Haehner A, Mayer AM, Landis BN, Pournaras I, Lill K, Gudziol V, Hummel T (2009) High test-retest reliability of the extended version of the “Sniffin’ Sticks” test. Chem Senses 34(8):705–711. doi:10.1093/chemse/bjp057 CrossRefPubMed

30.

Steinke JW, Borish L (2015) Factors driving the aspirin exacerbated respiratory disease phenotype. Am J Rhinol Allerg 29(1):35–40. doi:10.2500/ajra.2015.29.4123 CrossRef

31.

Chang HS, Shin SW, Lee TH, Bae DJ, Park JS, Kim YH, Uh ST, Choi BW, Kim MK, Choi IS, Park BL, Shin HD, Park CS (2015) Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study. Pharmacogenom J 15(4):316–321. doi:10.1038/tpj.2014.78 CrossRef

32.

Gudziol V, Lotsch J, Hahner A, Zahnert T, Hummel T (2006) Clinical significance of results from olfactory testing. Laryngoscope 116(10):1858–1863CrossRefPubMed

33.

Cho KS, Soudry E, Psaltis AJ, Nadeau KC, McGhee SA, Nayak JV, Hwang PH (2014) Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg 151(4):575–581. doi:10.1177/0194599814545750 CrossRefPubMed

34.

Lind H, Joergensen G, Lange B, Svendstrup F, Kjeldsen AD (2016) Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study. Eur Arch Otorhinolaryngol 273(4):911–919. doi:10.1007/s00405-015-3667-9 CrossRefPubMed

35.

Amar YG, Frenkiel S, Sobol SE (2000) Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter’s triad. J Otolaryngol 29(1):7–12PubMed

Titel: Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study
verfasst von: V. Gudziol
M. Michel
C. Sonnefeld
D. Koschel
T. Hummel
Publikationsdatum: 09.11.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2017
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-016-4366-x

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

The importance of obstructive sleep apnoea and hypopnea pathophysiology for customized therapy

Multi-slice SPECT/CT vs. lymphoscintigraphy and intraoperative gamma ray probe for sentinel node mapping in HNSCC

Laser tracheobronchoplasty: a novel technique for the treatment of symptomatic tracheobronchomalacia

Impact of control of blood glucose level during treatment of sudden deafness in diabetics: relationship with prognosis

A 3-D analysis of the protympanum in human temporal bones with chronic ear disease

Chronic rhinosinusitis with nasal polyps is associated with chronic otitis media in the elderly

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO